MedTrace Logo

Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)

NCT00279344 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2012-05-07

No results posted yet for this study

Summary

Primary objectives:

* To determine non-inferiority of FITpatch with regard to efficacy compared to standard opioid treatment
* To assess the safety of FITpatch compared to standard opioid treatment

Secondary objectives:

* To assess the intake of oral morphine as rescue analgesic to FITpatch compared to standard opioid treatment
* To assess Quality of life reported with FITpatch compared to standard opioid treatment

Conditions

  • Standard Opioid Analgesic Treatment of Cancer-related Chronic Pain.

Interventions

DRUG

Fentanyl (Matrifen)

Sponsors & Collaborators

  • Nycomed

    lead INDUSTRY

Principal Investigators

  • Nycomed Clinical Project Management · Headquaters

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Completion
2007-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00279344 on ClinicalTrials.gov